Clinical Trials Browser

Hodgkin Disease

Breast Neoplasms

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Leiomyosarcoma, Sarcoma

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Hodgkin Disease, Recurrence

Invasive Breast Cancer

Lymphoma, Large B-Cell, Diffuse

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

HER-2 Positive Breast Cancer

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

HER2-negative Breast Cancer

Liposarcoma, Sarcoma

Her2-negative Metastatic Breast Cancer

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasms

Triple Negative Breast Neoplasms

Hodgkin Disease

Multiple Myeloma

Hodgkin Disease

Breast Neoplasms

Breast Neoplasms

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms

Advanced Breast Cancer

Breast Neoplasms

Leukemia, Myeloid, Acute

Carcinoma, Ovarian Epithelial

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Mesothelioma, Malignant

Lymphoma, T-Cell, Peripheral

Burkitt Lymphoma, Lymphoma

Muscle Invasive Bladder Cancer

Ovarian Neoplasms

Multiple Myeloma

Clinical Trials

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

CARABELA

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

CemiHALT

BV mini CHP

DOVE

InCITe

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

met-HEReMYTA

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

SAFIR02_Breast

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

ORIENTA

First-line Treatment of Advanced/unresectable DDLPS

EASOVCWDITHABC

ALICE

ICON

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

BV-AVD-R Treatment Children Hodgkin's Lymphoma

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Brentuximab for Newly Diagnosed Hodgkin Disease

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)

Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC

Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer

PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer

Metronomic PLD in Patients With Primary Endocrine Resistant ABC

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

CLIO

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

MITO27

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade